-
Hymon® Respiratory Triplex Panel Test Kit
Hymon® Respiratory Triplex Panel Test Kit applies innovative “one-step method” to solve the cumbersome problem of nucleic acid extraction for SARS-CoV-2, influenza A and influenza B viruses; The nucleic acid is automatically released in 3 minutes, with sample-to-results as short as 35 minutes. Based on MoLock (nano-antibody molecular lock technology) and dual internal standard design, it achieves high sensitivity, high specificity, and full-process monitoring. A single tube can help detect COVID-19 N and E genes, influenza A and influenza B viruses by multiplex testing.
-
Hymon® SARS-CoV-2 Test Kit
Hymon® SARS-CoV-2 Test Kit provides in vitro detection of the coronavirus SARS-CoV-2 in nasopharyngeal/oropharyngeal swab and other respiratory samples. The virus infects human and causes COVID-19.
This test kit has received US FDA Emergency Use Authorization and European Union CE Certificate.
-
Hymon® MULTONE™ Respiratory Panel Test Kit
Hymon® provides a flexible, quantitative PCR respiratory detection solution for quick and sensitive clinical testing, and provide accurate detection results for some of the most common respiratory diseases. Hymon® MULTONE™ Respiratory Panel Test Kit adopts multiple qPCR technology and provides a combination panel for simultaneously detecting 12 different pathogens.
-
Hymon® Klebsiella Pneumoniae Detection Kit
This kit uses RT-PCR for in vitro detection of Klebsiella pneumoniae in nasopharyngeal and/or oropharyngeal swabs, sputum, bronchoalveolar lavage fluid, serum and plasma samples. Test results may serve as a reference for clinical evaluation of Klebsiella pneumonia infection.
Based on high-efficiency enzymatic processing technology, sample processing and purification are simultaneously completed in one tube to release and stabilize the pathogen nucleic acid.
The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® Legionella Detection Kit
This kit uses RT-PCR for in vitro detection of Legionella in sputum, bronchalveolar lavage fluid, serum, plasma, and other samples. Test results may serve as a reference for clinical evaluation of Legionella infection.
Based on high-efficiency enzymatic processing technology, the test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® Legionella Pneumophila Detection Kit
This kit uses RT-PCR for in vitro detection of Legionella pneumophila in nasopharyngeal and/or oropharyngeal swab, sputum, bronchoalveolar lavage fluid, serum, and plasma samples. Test results may serve as a reference for clinical evaluation of Legionella pneumophila infection.
Based on high-efficiency enzymatic processing technology, sample processing and purification are simultaneously completed in one tube to release and stabilize the pathogen nucleic acid.
The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® Haemophilus Influenzae Detection Kit
This kit uses RT-PCR for in vitro detection of Haemophilus influenzae in nasopharyngeal and/or oropharyngeal swabs, sputum, bronchoalveolar lavage fluid, serum, and plasma samples. Test results may serve as a reference for clinical evaluation of Haemophilus influenzae infection.
Based on high-efficiency enzymatic processing technology, sample processing and purification are simultaneously completed in one tube to release and stabilize the pathogen nucleic acid.
The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® Acinetobacter Baumannii Detection Kit
This kit uses RT-PCR for in vitro detection of Acinetobacter baumannii in sputum, bronchoalveolar lavage fluid, serum, plasma, and other samples. Test results may serve as a reference for clinical evaluatio nof Acinetobacter baumannii infection.
Based on high-efficiency enzymatic processing technology, the test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® Streptococcus Pneumoniae Detection Kit
This kit uses RT-PCR for in vitro detection of Streptococcus pneumoniae in nasopharyngeal and/or oropharyngeal swab, sputum, bronchoalveolar lavage fluid, serum, and plasma samples. Test results may serve as a reference for clinical evaluation of Streptococcus pneumoniae infection.
Based on high-efficiency enzymatic processing technology, sample process and purification are simultaneously completed in one tube to release and stabilize the pathogen nucleic acid.
The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® Bocavirus Detection Kit
This kit uses RT-PCR for in vitro detection of bocavirus in nasopharyngeal and/or oropharyngeal swab samples. Test results may serve as a reference for clinical evaluation of bocavirus infection.
Based on high-efficiency enzymatic processing technology, sample processing and purification are simultaneously completed in one tube to release and stabilize the pathogen nucleic acid.
The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® Coronavirus 229E/OC43/NL63/HKU1 Detection Kit
This kit uses RT-PCR for in vitro detection of coronavirus 229E, OC43, NL63, and HKU1 in nasopharyngeal and/or oropharnygeal swam samples. Test results may serve as a reference for clinical evaluation of coronavirus 229E, OC43, NL62, and HKU1.
Based on high-efficiency enzymatic processing technology, sample processing and purification are simultaneously completed in one tube to release and stabilize the pathogen nucleic acid.
The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
-
Hymon® MERS CoV Detection Kit
This kit uses RT-PCR for in vitro detection of MERS-CoV in nasopharyngeal and/or oropharyngeal swab samples. Test results may serve as a reference for clincial evaluation fo MERS-CoV infection. Based on high-efficiency enymatic processing technology, sample processing and purification are simultaneously completed in on etube to release and stabilize the pathogen nucleic acid. The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
